We herein summarise the evidence concerning the impact of sperm DNA fragmentation in
various clinical infertility scenarios and the advances on sperm DNA fragmentation tests …

Objective Approximately 37% of men of reproductive age smoke cigarettes, with Europe
having the highest tobacco use among all the World Health Organization (WHO) regions …

Sperm DNA fragmentation (SDF) has been generally acknowledged as a valuable tool for
male fertility evaluation. While its detrimental implications on sperm function were …

Objective To explore the current evidence concerning the effect of oral antioxidant
supplementation on various male fertility outcomes, as antioxidants are widely available …

It is estimated that infertility affects 8–12% of couples globally, with a male factor being a
primary or contributing cause in approximately 50% of couples. Causes of male subfertility …

The novel coronavirus was recognised in December 2019 and caught humanity off guard.
The virus employs the angiotensin‐converting enzyme 2 (ACE2) receptor for entry into …

Clinical infertility is the inability of a couple to conceive after 12 months of trying. Male factors
are estimated to contribute to 30–50% of cases of infertility. Infertility or reduced fertility can …

The diagnosis of male infertility relies largely on conventional semen analysis, and its
interpretation has a profound influence on subsequent management of patients. Despite …

The differential diagnosis between obstructive and nonobstructive azoospermia is the first
step in the clinical management of azoospermic patients with infertility. It includes a detailed …

The clinical management of men with nonobstructive azoospermia (NOA) seeking fertility
has been a challenge for andrologists, urologists, and reproductive medicine specialists …